The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Extent of Disease at Presentation and Outcome for Adrenocortical Carcinoma: Have We Made Progress?
Abstract
BACKGROUND: Adrenocortical carcinoma (ACC), a rare and aggressive malignancy, accounts for up to 14% of adrenal incidentalomas. The only chance of cure for ACC is diagnosis at an early stage; therefore, a main indication for adrenalectomy in patients with adrenal incidentaloma has been the potential risk of ACC. Recent studies suggest that this has led to earlier stage of ACC at diagnosis, more curative operations, and better survival. METHODS: We analyzed data on ACC from The National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) database. Four equal time quartiles (1973-1979, 1980-1986, 1987-1993, and 1994-2000) were compared for changes in demographics, pathology, treatment, and cause-specific mortality. RESULTS: The average age was 51.2 years (range: 1-97), and 45.9% of patients were men. The average tumor size was 12 cm (range: 2-36 cm), and only 4.2% were < or = 6 cm. Most (88%) patients had surgical resection of their tumor, and external beam radiotherapy was used in only 12% of patients. Between the time quartiles compared (as well as annually), there was no significant difference at presentation in age at diagnosis, sex, race/ethnicity, tumor size, tumor grade, the frequency of distant metastasis, and overall TNM stage. Low tumor grade, lower stage of ACC, later time quartile, and surgical resection were associated with a lower cause-specific mortality by univariate analysis (P < or = 0.002) and by multivariate analysis (P < or = 0.031). CONCLUSIONS: Although adrenal incidentalomas have become a common indication for adrenalectomy, this has not resulted in patients with ACC being diagnosed earlier or treated at a lower stage of disease at the national level. The most important predictors of survival in these patients are tumor grade, tumor stage, and surgical resection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Surveillance, Epidemiology, and End Results (SEER) database provides an estimation of incidence of approximately 0.72 per million cases per year leading to 0.2% of all cancer deaths in the United States (4).”
From Adrenocortical carcinoma (2014) · cites this paper as [4]
In the citing paper
“In the United States, it is used in approximately 10% of cases, according to analyses of both the National Cancer Data Base and the SEER program (4, 11, 90).”
From Adrenocortical carcinoma (2014) · cites this paper as [4]
Citations
Cites
The clinically inapparent adrenal mass: update in diagnosis and management
Mansmann, G., Lau, J., Balk, E., Rothberg, M., Miyachi, Y., & Bornstein, S. R. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0031 · Cited by 781
Icard, P., Goudet, P., Charpenay, C., Andreassian, B., Carnaille, B., Chapuis, Y., Cougard, P., Henry, J., & Proye, C. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0047-y · Cited by 543
Dackiw, A. P. B., Lee, J. E., Gagel, R. F., & Evans, D. B. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0030-7 · Cited by 390
Schulick, R. D., & Brennan, M. F. (1999) · Annals of Surgical Oncology · doi:10.1007/s10434-999-0719-7 · Cited by 366
Adrenocortical Carcinoma: Clinical, Morphologic, and Molecular Characterization
Stojadinovic, A., Ghossein, R. A., Hoos, A., Nissan, A., Marshall, D., Dudas, M. E., Cordon‐Cardo, C., Jaques, D. P., & Brennan, M. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.4.941 · Cited by 312
de Fraipont, F., El Atifi, M., Cherradi, N., Le Moigne, G., Defaye, G., Houlgatte, R., Bertherat, J., Bertagna, X., Plouin, P.-F., Baudin, E., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1075 · Cited by 261
Survival Variability by Race and Ethnicity in Childhood Acute Lymphoblastic Leukemia
Kadan‐Lottick, N. S. (2003) · JAMA · doi:10.1001/jama.290.15.2008 · Cited by 238
Management of adrenocortical carcinoma
Allolio, B., Hahner, S., Weismann, D., & Fassnacht, M. (2004) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01881.x · Cited by 214
Kendrick, M. L. (2001) · Archives of Surgery · doi:10.1001/archsurg.136.5.543 · Cited by 140
Pathologic Features of Prognostic Significance for Adrenocortical Carcinoma After Curative Resection
Harrison, L. E. (1999) · Archives of Surgery · doi:10.1001/archsurg.134.2.181 · Cited by 117
Research works printed but not linked: 1
- 10.1200/JCO.20.4.941 · DOI
Cited by
Sorted by citations
Items 101–200 of 450
Characteristics of Adrenocortical Carcinoma Associated With Lynch Syndrome
Doménech, M., Grau, È., Solanes, A., Izquierdo, Á., Valle, J. D., Carrato, C., Pineda, M., Dueñas, N., Pujol, M., Lázaro, C., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa833 · Cited by 37
Surgical management of adrenal tumors
Germain, A., Klein, M., & Brunaud, L. (2011) · Journal of Visceral Surgery · doi:10.1016/j.jviscsurg.2011.06.003 · Cited by 37
Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism
Russo, M., Scollo, C., Pellegriti, G., Cotta, O. R., Squatrito, S., Frasca, F., Cannavò, S., & Gullo, D. (2016) · Clinical Endocrinology · doi:10.1111/cen.12868 · Cited by 36
The Current Status of Laparoscopic Adrenalectomy
Ariyan, C. E., & Strong, V. E. M. (2007) · Advances in Surgery · doi:10.1016/j.yasu.2007.05.008 · Cited by 36
Daher, M., Varghese, J. M., Gruschkus, S. K., Jiménez, C., Waguespack, S. G., Bedrose, S. S. D., Altameemi, L., Bazerbashi, H., Naing, A., Subbiah, V., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac046 · Cited by 35
Hadjadj, D., Kim, S.-J., Denecker, T., Driss, L. B., Cadoret, J., Maric, C. A., Baldacci, G., & Fauchereau, F. (2017) · Aging · doi:10.18632/aging.101356 · Cited by 37
Ozsari, L., Kutahyalioglu, M., Elsayes, K. M., Vicens, R., Sircar, K., Jazaerly, T., Waguespack, S. G., Busaidy, N. L., Cabanillas, M. E., Dadu, R., et al. (2015) · Endocrine · doi:10.1007/s12020-015-0694-7 · Cited by 35
Langenhuijsen, J. F., Birtle, A. J., Klatte, T., Porpiglia, F., & Timsit, M. (2015) · European Urology Focus · doi:10.1016/j.euf.2015.12.001 · Cited by 34
Gara, S. K., Wang, Y., Patel, D., Liu‐Chittenden, Y., Jain, M., Boufraqech, M., Zhang, L., Meltzer, P. S., & Kebebew, E. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv908 · Cited by 34
MicroRNA Expression Profiling in Adrenal Myelolipoma
Decmann, Á., Perge, P., Nyírő, G., Darvasi, O., Likó, I., Borka, K., Micsík, T., Tóth, Z., Bancos, I., Pezzani, R., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00817 · Cited by 34
Liu‐Chittenden, Y., Jain, M., Kumar, P., Patel, D., Aufforth, R., Neychev, V. K., Sadowski, S. M., Gara, S. K., Joshi, B. H., Cottle‐Delisle, C., et al. (2015) · Cancer Medicine · doi:10.1002/cam4.449 · Cited by 33
Mochizuki, T., Kawahara, T., Takamoto, D., Makiyama, K., Hattori, Y., Teranishi, J., Miyoshi, Y., Yumura, Y., Yao, M., & Uemura, H. (2017) · BMC Urology · doi:10.1186/s12894-017-0240-4 · Cited by 32
Mass Spectrometry-Based Proteomic Discovery of Prognostic Biomarkers in Adrenal Cortical Carcinoma
Jang, H. N., Moon, S. J., Jung, K. C., Kim, S. W., Kim, H., Han, D., & Kim, J. H. (2021) · Cancers · doi:10.3390/cancers13153890 · Cited by 32
Jiménez, C., Armaiz-Peña, G., Dahia, P. L. M., Lü, Y., Toledo, R. A., Varghese, J. M., & Habra, M. A. (2022) · Cancers · doi:10.3390/cancers14030467 · Cited by 29
Advances in translational research of the rare cancer type adrenocortical carcinoma
Ghosh, C., Hu, J., & Kebebew, E. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00623-0 · Cited by 34
Cabozantinib monotherapy for advanced adrenocortical carcinoma: a single-arm, phase 2 trial
Campbell, M. T., Balderrama-Brondani, V., Jiménez, C., Tamsen, G., Marcal, L. P., Varghese, J. M., Shah, A. Y., Long, J. P., Zhang, M., Ochieng, J. K., et al. (2024) · The Lancet Oncology · doi:10.1016/s1470-2045(24)00095-0 · Cited by 31
Comparison between functional and non-functional adrenocortical carcinoma
Sada, A., Asaad, M., Bews, K. A., Thompson, G. B., Young, W. F., Bancos, I., Farley, D. R., Dy, B. M., Lyden, M. L., Habermann, E. B., et al. (2019) · Surgery · doi:10.1016/j.surg.2019.04.066 · Cited by 31
Metabolic and Endocrine Toxicities of Mitotane: A Systematic Review
Bianchini, M., Puliani, G., Chiefari, A., Mormando, M., Lauretta, R., & Appetecchia, M. (2021) · Cancers · doi:10.3390/cancers13195001 · Cited by 34
Maurice, M. J., Bream, M. J., Kim, S. P., & Abouassaly, R. (2016) · British Journal of Urology · doi:10.1111/bju.13618 · Cited by 31
Methylation of IGF2 regulatory regions to diagnose adrenocortical carcinomas
Creemers, S. G., van Koetsveld, P. M., van Kemenade, F. J., Papathomas, T. G., Franssen, G. J. H., Dogan, F., Eekhoff, E. M. W., van der Valk, P., de Herder, W. W., Janssen, J. A. M. J. L., et al. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0266 · Cited by 30
Adjuvant radiotherapy after surgical resection for adrenocortical carcinoma
Viani, G. A., & Viana, B. S. (2018) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_996_15 · Cited by 31
Establishing a human adrenocortical carcinoma (ACC)-specific gene mutation signature
Rahane, C. S., Kutzner, A., & Heese, K. (2018) · Cancer Genetics · doi:10.1016/j.cancergen.2018.10.005 · Cited by 30
Treatment with docetaxel and cisplatin in advanced adrenocortical carcinoma, a phase II study
Urup, T. H., Pawlak, W. Z., Petersen, R. H., Pappot, H., Rørth, M. R., & Daugaard, G. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.229 · Cited by 30
The role of radiation therapy in the management of adrenal carcinoma and adrenal metastases
Milgrom, S. A., & Goodman, K. A. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23096 · Cited by 30
Smith, P. M., Kiernan, C. M., Tran, T. B., Postlewait, L. M., Maithel, S. K., Prescott, J. D., Pawlik, T. M., Wang, T. S., Glenn, J. A., Hatzaras, I. S., et al. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6546-y · Cited by 30
Kutikov, A., Mallin, K., Canter, D. J., Wong, Y., & Uzzo, R. G. (2011) · The Journal of Urology · doi:10.1016/j.juro.2011.04.072 · Cited by 30
Tierney, J. F., Chivukula, S. V., Poirier, J., Pappas, S. G., Schadde, E., Hertl, M., Kebebew, E., & Keutgen, X. M. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00915 · Cited by 30
Screening and Identification of Potential Prognostic Biomarkers in Adrenocortical Carcinoma
Xu, W.-H., Wu, J., Wang, J., Wan, F., Wang, H., Cao, D., Qu, Y.-Y., Zhang, H., & Ye, D. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00821 · Cited by 29
Aktuelle TNM-Klassifikationssysteme für das Nebennierenkarzinom
Faßnacht, M., Wittekind, C., & Allolio, B. (2010) · Der Pathologe · doi:10.1007/s00292-010-1306-1 · Cited by 29
Tran, T. B., Maithel, S. K., Pawlik, T. M., Wang, T. S., Hatzaras, I. S., Phay, J. E., Fields, R. C., Weber, S. M., Sicklick, J. K., Yopp, A. C., et al. (2016) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2016.08.568 · Cited by 29
Terzolo, M., & Faßnacht, M. (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0260 · Cited by 30
Incidentalomas – A “disease” of modern imaging technology
Wagner, J., & Aron, D. C. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.08.006 · Cited by 28
Interleukin‐13 receptor alpha2 is a novel therapeutic target for human adrenocortical carcinoma
Jain, M., Zhang, L., He, M., Patterson, E. E., Nilubol, N., Fojo, A. T., Joshi, B. H., Puri, R. K., & Kebebew, E. (2012) · Cancer · doi:10.1002/cncr.27629 · Cited by 28
Huang, Y., Wang, Y., Zhu, R., Tang, K., Tang, X.-B., & Su, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.771579 · Cited by 27
Outcome of immunotherapy in adrenocortical carcinoma: a retrospective cohort study
Remde, H., Schmidt-Pennington, L., Reuter, M., Landwehr, L., Jensen, M., Lahner, H., Kimpel, O., Altieri, B., Laubner, K., Schreiner, J., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad054 · Cited by 27
The effect of hormonal secretion on survival in adrenocortical carcinoma: A multi-center study
Sada, A., Foster, T. R., Al-Ward, R., Sawani, S., Charchar, H. L. S., Pishdad, R., Ben-Shlomo, A., Dy, B. M., Lyden, M. L., Bergsland, E. K., et al. (2023) · Surgery · doi:10.1016/j.surg.2023.04.070 · Cited by 28
External validation of a nomogram predicting mortality in patients with adrenocortical carcinoma
Laurent Zini, A., Umberto Capitanio, A., Claudio Jeldres, A., Giovanni Lughezzani, A., Sun, M., Shariat, S. F., Hendrik Isbarn, A., Arjane, P., Widmer, H., Perrotte, P., et al. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.08660.x · Cited by 25
Comparative Efficacy of Laparoscopic Versus Robotic Adrenalectomy for Adrenal Malignancy
Mishra, K., Maurice, M. J., Bukavina, L., & Abouassaly, R. (2018) · Urology · doi:10.1016/j.urology.2018.08.037 · Cited by 25
Mimics, pitfalls, and misdiagnoses of adrenal masses on CT and MRI
Elsayes, K. M., Elmohr, M. M., Javadi, S., Menias, C. O., Remer, E. M., Morani, A. C., & Shaaban, A. M. (2019) · Abdominal Radiology · doi:10.1007/s00261-019-02082-4 · Cited by 26
A review of mitotane in the management of adrenocortical cancer
Rivero, J. D., Else, T., Johnson, J. E. H., Kiseljak‐Vassiliades, K., Raj, N. P., Reidy‐Lagunes, D. L., Srinivas, S., Gilbert, J., Vaidya, A., Aboujaoude, E., et al. (2024) · The Oncologist · doi:10.1093/oncolo/oyae084 · Cited by 24
Macroscopic Fat in Adrenocortical Carcinoma: A Systematic Review
Ranathunga, D. S., Cherpak, L. A., Schieda, N., Flood, T. A., & McInnes, M. D. F. (2019) · American Journal of Roentgenology · doi:10.2214/ajr.19.21851 · Cited by 24
First case report of an adrenocortical carcinoma caused by a BRCA2 mutation
Ghorayeb, N. E., Grunenwald, S., Nolet, S., Primeau, V., Côté, S., Maugard, C. M., Lacroix, A., Gaboury, L. A., & Bourdeau, I. (2016) · Medicine · doi:10.1097/md.0000000000004756 · Cited by 24
Pathological and Genetic Stratification for Management of Adrenocortical Carcinoma
Clay, M. R., Pinto, E. M., Fishbein, L. M., Else, T., & Kiseljak‐Vassiliades, K. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab866 · Cited by 24
Cyclin A and cyclin B1 overexpression in differentiated thyroid carcinoma
Nar, A., Özen, Ö., Tütüncü, N. B., & Demirhan, B. (2011) · Medical Oncology · doi:10.1007/s12032-010-9800-0 · Cited by 23
Li, Y., Bian, X., Ouyang, J., Wei, S., He, M., & Luo, Z. (2018) · Cancer Management and Research · doi:10.2147/cmar.s187169 · Cited by 23
Poirier, J., Gagnon, N., Terzolo, M., Puglisi, S., Ghorayeb, N. E., Calabrese, A., Lacroix, A., & Bourdeau, I. (2020) · Cancers · doi:10.3390/cancers12030639 · Cited by 23
Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women
Elhassan, Y., Hawley, J. M., Cussen, L., Abbara, A., Clarke, S. A., Kempegowda, P., Dhillon‐Smith, R. K., Thadani, P., Busby, M., Owusu‐Darkwah, L., et al. (2025) · Clinical Endocrinology · doi:10.1111/cen.15265 · Cited by 25
Multimodality Imaging of Abdominopelvic Tumors with Venous Invasion
LeGout, J. D., Bailey, R. E., Bolan, C. W., Bowman, A. W., Chen, F., Cernigliaro, J. G., & Alexander, L. F. (2020) · Radiographics · doi:10.1148/rg.2020200047 · Cited by 22
microRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma
Kwok, G., Zhao, J., Glover, A. R., Gill, A. J., Clifton-Bligh, R. J., Robinson, B. G., Ip, J. C. Y., & Sidhu, S. B. (2019) · The Oncologist · doi:10.1634/theoncologist.2018-0849 · Cited by 24
Haider, M. S., Schreiner, J., Kendl, S., Kroiß, M., & Luxenhofer, R. (2019) · Macromolecular Bioscience · doi:10.1002/mabi.201900178 · Cited by 21
Clinical and molecular prognostic factors in adrenocortical carcinoma
Libé, R. (2018) · Minerva Endocrinology · doi:10.23736/s0391-1977.18.02900-0 · Cited by 21
The Immunotherapy Landscape in Adrenocortical Cancer
Pegna, G. J., Roper, N., Kaplan, R. N., Bergsland, E. K., Kiseljak‐Vassiliades, K., Habra, M. A., Pommier, Y. G., & Rivero, J. D. (2021) · Cancers · doi:10.3390/cancers13112660 · Cited by 22
Creemers, S. G., van Koetsveld, P. M., van den Dungen, E. S. R., Korpershoek, E., van Kemenade, F. J., Franssen, G. J. H., de Herder, W. W., Feelders, R. A., & Hofland, L. J. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2768 · Cited by 21
Circadian rhythm disruption and endocrine-related tumors
Savvidis, C., Kallistrou, E., Kouroglou, E., Dionysopoulou, S., Gavriiloglou, G., Ragia, D., Tsiama, V., Proikaki, S., Belis, K., & Ilias, Ι. (2024) · World Journal of Clinical Oncology · doi:10.5306/wjco.v15.i7.818 · Cited by 24
Genetic Alterations in Benign Adrenal Tumors
Pitsava, G., & Stratakis, C. A. (2022) · Biomedicines · doi:10.3390/biomedicines10051041 · Cited by 20
Epidemiological risk factors for adrenocortical carcinoma: A hospital‐based case–control study
Habra, M. A., Sukkari, M. A., Hasan, A., Albousen, Y., Elsheshtawi, M. A., Jiménez, C., Campbell, M. T., Karam, J. A., Graham, P. H., Hatia, R. I., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32534 · Cited by 20
The Efficacy of Mitotane in Human Primary Adrenocortical Carcinoma Cultures
van Koetsveld, P. M., Creemers, S. G., Dogan, F., Franssen, G. J. H., de Herder, W. W., Feelders, R. A., & Hofland, L. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz001 · Cited by 21
Brain Metastasis in Patients With Adrenocortical Carcinoma: A Clinical Series
Burotto, M., Tageja, N., Rosenberg, A. Z., Mahalingam, S., Quezado, M., Velarde, M., Edgerly, M., & Fojo, T. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2650 · Cited by 19
Key MicroRNA’s and Their Targetome in Adrenocortical Cancer
Chehade, M., Bullock, M., Glover, A. R., Hutvágner, G., & Sidhu, S. B. (2020) · Cancers · doi:10.3390/cancers12082198 · Cited by 20
Ghorayeb, N. E., Rondeau, G., Latour, M., Cohade, C., Olney, H. J., Lacroix, A., Perrotte, P., Sabourin, A., Mazzuco, T. L., & Bourdeau, I. (2016) · Medicine · doi:10.1097/md.0000000000003180 · Cited by 20
Heat Shock Protein 90 as a Prognostic Marker and Therapeutic Target for Adrenocortical Carcinoma
Siebert, C., Ciato, D., Murakami, M., Frei‐Stuber, L., Perez‐Rivas, L. G., Garcia, J. L. M., Nölting, S., Maurer, J., Feuchtinger, A., Walch, A. K., et al. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00487 · Cited by 23
Metastatic Adrenocortical Carcinoma: a Single Institutional Experience
Owen, D. H., Patel, S. H., Wei, L., Phay, J. E., Shirley, L. A., Kirschner, L. S., Schmidt, C. R., Abdel‐Misih, S., Brock, P. L., Shah, M. H., et al. (2019) · Hormones and Cancer · doi:10.1007/s12672-019-00367-0 · Cited by 20
Knott, E. L., & Leidenheimer, N. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228485 · Cited by 19
Clay, M. R., Pinto, E. M., Cline, C., Tran, Q. T., Lin, T., Dyer, M. A., Shi, L. G., Wu, H., Pounds, S. B., Zambetti, G. P., et al. (2019) · JCO Precision Oncology · doi:10.1200/po.19.00163 · Cited by 21
Poorman, C. E., Ethun, C. G., Postlewait, L. M., Tran, T. B., Prescott, J. D., Pawlik, T. M., Wang, T. S., Glenn, J. A., Hatzaras, I. S., Shenoy, R. S., et al. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-6236-1 · Cited by 18
Xing, Z., Luo, Z., Yang, H., Huang, Z., & Liang, X. (2019) · Oncology Letters · doi:10.3892/ol.2019.10817 · Cited by 18
Epidemiology of Adrenocortical Carcinoma
Faßnacht, M., & Allolio, B. (2009) · Springer eBooks · doi:10.1007/978-0-387-77236-3_3 · Cited by 18
Integrative computational immunogenomic profiling of cortisol‐secreting adrenocortical carcinoma
Baechle, J. J., Hanna, D. N., Sekhar, K. R., Rathmell, J. C., Rathmell, W. K., & Baregamian, N. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16936 · Cited by 17
Cheng, Y., Kou, W., Zhu, D., Yu, X., & Zhu, Y. T. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.811293 · Cited by 18
Preclinical Models of Adrenocortical Cancer
Sedlack, A. J. H., Hatfield, S. J., Kumar, S., Arakawa, Y., Roper, N., Sun, N.-Y., Nilubol, N., Kiseljak‐Vassiliades, K., Hoang, C. D., Bergsland, E. K., et al. (2023) · Cancers · doi:10.3390/cancers15112873 · Cited by 17
Characteristics of adrenocortical carcinoma in South Korea: a registry-based nationwide survey
Lim, J. S., Lee, S., Kim, J. H., Kim, J. H., & _, _. (2020) · Endocrine Connections · doi:10.1530/ec-20-0196 · Cited by 17
Balderrama-Brondani, V., Lacombe, A. M. F., Mariani, B. M. P., Montenegro, L. R., Soares, I. C., Neto, J. E. B., Tanno, F. Y., Srougi, V., Chambo, J. L., Mendonca, B. B., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031238 · Cited by 17
Preclinical assessment of synergistic efficacy of MELK and CDK inhibitors in adrenocortical cancer
Laha, D., Grant, R., Mishra, P., Boufraqech, M., Shen, M., Zhang, Y., Hall, M. D., Quezado, M., Melo, M. S. D., Rivero, J. D., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02464-5 · Cited by 17
Chomsky‐Higgins, K. H., Seib, C. D., Rochefort, H. M., Gosnell, J. E., Shen, W. T., Kahn, J. G., Duh, Q., & Suh, I. (2017) · Surgery · doi:10.1016/j.surg.2017.07.030 · Cited by 16
Yousaf, A., Patterson, J., Hobbs, G. R., Davis, S. M., Yousaf, M., Hafez, M., Albandar, H. J., Hogan, T. F., & Kolodney, J. A. (2020) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2020.100206 · Cited by 16
Adrenocortical carcinoma: What the surgeon needs to know. Case report and literature review
Benassai, G., Desiato, V., Benassai, G., Bianco, T., Sivero, L., Compagna, R., Vigliotti, G., Limite, G., Amato, B., & Quarto, G. (2014) · International Journal of Surgery · doi:10.1016/j.ijsu.2014.05.030 · Cited by 16
Ikeya, A., Nakashima, M., Yamashita, M., Kakizawa, K., Okawa, Y., Saitsu, H., Sasaki, S., Sasano, H., Suda, T., & Oki, Y. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231665 · Cited by 16
Subramanian, C., & Cohen, M. S. (2021) · Surgery · doi:10.1016/j.surg.2021.04.049 · Cited by 16
Margonis, G. A., Amini, N., Kim, Y., Tran, T. B., Postlewait, L. M., Maithel, S. K., Wang, T. S., Evans, D. B., Hatzaras, I. S., Shenoy, R. S., et al. (2015) · World Journal of Surgery · doi:10.1007/s00268-015-3307-y · Cited by 17
Hu, Z., Yang, S., Xu, Z., Zhang, X., Wang, H., Fan, G., & Liao, X. (2023) · Aging · doi:10.18632/aging.205224 · Cited by 15
Personalized Care of Patients with Adrenocortical Carcinoma: A Comprehensive Approach
Miller, B. S., & Else, T. (2017) · Endocrine Practice · doi:10.4158/ep161719.ra · Cited by 15
Tumor in the veins: an abdominal perspective with an emphasis on CT and MR imaging
Karaosmanoğlu, A. D., Onur, M. R., Uysal, A., Akata, D., Ozmen, M. N., & Karçaaltıncaba, M. (2020) · Insights into Imaging · doi:10.1186/s13244-020-00854-x · Cited by 15
Baechle, J. J., Smith, P. M., Solórzano, C. C., Tran, T. B., Postlewait, L. M., Maithel, S. K., Prescott, J. D., Pawlik, T. M., Wang, T. S., Glenn, J. A., et al. (2021) · Annals of Surgical Oncology · doi:10.1245/s10434-020-09562-8 · Cited by 15
Disparities in access to care and outcomes in patients with adrenocortical carcinoma
Hammad, A. Y., Yen, T. W. F., Carr, A. A., Evans, D. B., & Wang, T. S. (2017) · Journal of Surgical Research · doi:10.1016/j.jss.2017.02.046 · Cited by 16
Bulzico, D., de Faria, P. A. S., de Paula, M. P., Bordallo, M. A. N., Pessoa, C. H. C. N., Corbo, R., Ferman, S., Vaisman, M., & Neto, L. V. (2016) · Pediatric Hematology and Oncology · doi:10.3109/08880018.2016.1173148 · Cited by 15
Review of Diagnostic Modalities for Adrenal Incidentaloma
Okrój, D., Rzepecka, A., Kłosowski, P., Babińska, A., & Sworczak, K. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12113739 · Cited by 17
Balderrama-Brondani, V., Griffin, A. M., Owen, T., Merriman, K. W., Chahla, B., Varghese, J. M., Jiménez, C., Waguespack, S. G., Graham, P. H., Perrier, N. D., et al. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.10.004 · Cited by 14
Li, W., Liu, R., Wei, D., Zhang, W., Zhang, H., Huang, W., & Hao, L. (2020) · BioMed Research International · doi:10.1155/2020/3501451 · Cited by 14
Uchihara, M., Tanioka, M., Kojima, Y., Nishikawa, T., Sudo, K., Shimoi, T., Noguchi, E., Maeshima, A. M., & Yonemori, K. (2021) · International Journal of Clinical Oncology · doi:10.1007/s10147-021-02021-8 · Cited by 14
Satoh, K., Patel, D., Dieckmann, W., Nilubol, N., & Kebebew, E. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4813-8 · Cited by 15
Gaitanidis, A., Wiseman, D., Lakis, M. E., Nilubol, N., Kebebew, E., & Patel, D. (2019) · Journal of Surgical Oncology · doi:10.1002/jso.25760 · Cited by 14
Venous thromboembolism in patients with adrenocortical carcinoma after surgery
Durmuşoğlu, J., Timmers, H. J. L. M., van Houten, P., Langenhuijsen, H. F., Hermus, A. R., & van de Ven, A. C. (2020) · Endocrine Connections · doi:10.1530/ec-20-0299 · Cited by 15
The indeterminate adrenal mass
Harrison, B. J. (2011) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-011-0845-0 · Cited by 14
Molecular markers and targeted therapies for adrenocortical carcinoma
Xu, Y., Qi, Y., Zhu, Y., Ning, G., & Huang, Y. (2013) · Clinical Endocrinology · doi:10.1111/cen.12358 · Cited by 13
Molecular genomic profiling of adrenocortical cancers in clinical practice
Darabi, S., Braxton, D. R., Eisenberg, B. L., & Demeure, M. J. (2020) · Surgery · doi:10.1016/j.surg.2020.05.039 · Cited by 13
Disorders of the adrenal cortex: Genetic and molecular aspects
Pitsava, G., Maria, A. G., & Faucz, F. R. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.931389 · Cited by 13
Advanced Adrenocortical Carcinoma: From Symptoms Control to Palliative Care
Ruggiero, E., Tizianel, I., Caccese, M., Lombardi, G., Pambuku, A., Zagonel, V., Scaroni, C. M., Formaglio, F., & Ceccato, F. (2022) · Cancers · doi:10.3390/cancers14235901 · Cited by 13
Adrenocortical carcinoma with delayed cutaneous metastasis
Satter, E. K., & Barnette, D. J. (2008) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2007.00870.x · Cited by 13
Adrenocortical carcinoma in children and adults: Two decades experience in a single institution
Mishra, A., Sabaretnam, M., Agarwal, G., Agarwal, A., Verma, A., & Mishra, S. K. (2016) · Indian Journal of Cancer · doi:10.4103/0019-509x.197737 · Cited by 13
Adrenalectomy for incidentaloma: lessons learned from a single‐centre series of 274 patients
Gaujoux, S., Aimé, A., Assié, G., Ciuni, R., Bonnet, S., Tenenbaum, F., Bertherat, J. Y., & Dousset, B. E. (2017) · ANZ Journal of Surgery · doi:10.1111/ans.14095 · Cited by 12
Metadata
- Authors
- Kebebew, E., Reiff, E., Duh, Q., Clark, O. H., & McMillan, A.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Kebebew, Electron
- Venue
- World Journal of Surgery
- Publisher
- Wiley
- Published
- 2006-03-10
- Volume
- 30
- Issue
- 5
- Pages
- 872-878
- ISSN
- 0364-2313 (ISSN-L)
- 1432-2323
- OpenAlex
- W2096051245
- Cited by
- 451
- References
- 21
- Citations by year
- 2026: 12 · 2025: 18 · 2024: 28 · 2023: 35 · 2022: 33 · 2021: 47 · 2020: 44 · 2019: 30 · 2018: 27 · 2017: 25 · 2016: 21 · 2015: 35 · 2014: 12 · 2013: 14 · 2012: 17
- FWCI
- 10.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- World Journal of Surgery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- adrenocortical carcinoma, adrenal incidentaloma, adrenalectomy, tumor size, tumor grade, TNM stage, distant metastasis, surgical resection, external beam radiotherapy, cause-specific mortality, survival predictors, temporal trends in diagnosis
- MeSH terms
- Adolescent, Adrenal Cortex Neoplasms, Adrenalectomy, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Female, Humans, Infant, Male, Middle Aged, Neoplasm Staging, Retrospective Studies, United States, Cohort Studies, Treatment Outcome, Adrenocortical Carcinoma, SEER Program, Radiotherapy, Adjuvant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review